New Product Development T2 Biosystems has a strong focus on developing innovative diagnostic products, including the T2Lyme Panel and expanded T2Candida Panel. The continuous development of new products presents sales opportunities to position these cutting-edge solutions in the market.

Partnership Expansion By partnering with organizations like Cardinal Health and Vizient, T2 Biosystems has enhanced its distribution network and market reach. Leveraging these partnerships presents sales opportunities to explore new channels and expand customer base.

Financial Stability With reported revenues between $10M to $50M and recent financing of $265K, T2 Biosystems demonstrates financial stability. This stability provides sales professionals with confidence in engaging with the company for potential collaborations or purchases.

Technology Advancements Utilizing a tech stack that includes React and Microsoft among others, T2 Biosystems showcases a commitment to technological advancements. Sales representatives can leverage this technological edge to highlight the innovative features of the company's products to potential clients.

Competitive Positioning Being an emerging leader in the field of in vitro diagnostics, T2 Biosystems holds a competitive position in the industry. This status opens up sales opportunities for positioning the company's products as cutting edge solutions ahead of competitors, appealing to healthcare professionals seeking advanced diagnostic tools.